HUM SEC Filing News — Humana Inc.

Latest SEC filings for Humana Inc. (HUM) explained in plain English. Covers insider buying and selling (Form 4), proposed insider sales (Form 144), material company events (8-K), and quarterly & annual reports (10-Q / 10-K). StrongBuyAnalytics provides navigation and brief excerpts or summaries; original filings remain at the SEC/source links and were authored by their filers, not StrongBuyAnalytics. Filing dates shown are source dates. Coverage and detection can be delayed or incomplete because of SEC availability, amendments, parsing, caching, or outages. Latest source filing date shown: 2026-10-13.

Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance c…
Sector: Healthcare Industry: Healthcare Plans Market Cap: $51.3B CIK: 49071
20
Total Filings
0
Bullish Classifications
0
Bearish Classifications
12
Insider Transactions
7
Material Events (8-K)
1
Periodic Reports
What you're looking at: Each item below is parsed from an actual SEC filing submitted by Humana Inc.. Form 4 = confirmed insider transaction · Form 144 = proposed sale notice · 8-K = material event (earnings, M&A, leadership change, etc.) · 10-Q / 10-K = quarterly / annual report.
HUM Filing Activity Snapshot 2026-05-05 — 2026-10-13
Insider Transactions (Form 4)
0 buys vs 0 sells
Insider buying and selling activity is balanced in this period.
Insider Transactions 12 · Forms 3, 4 and 5

A Form 4 is filed within two business days of a company insider — an officer, a director, or a holder of more than ten percent of the stock — changing their position in the shares. All 12 filings in this group are Form 4s for Humana Inc.

The difficulty with reading these filings as a group is that a single form type covers transactions that mean entirely different things. An executive spending their own money to buy stock and an executive having shares withheld to pay tax on a vesting grant both appear as a Form 4. Every filing below is therefore tagged with the nature of the underlying transaction, taken from the transaction code reported on the form itself.

Across the 12 insider filings shown, the breakdown is 12 compensation award. None of the classified filings involved a discretionary open-market trade, so this period says nothing about what insiders think of the price.

What each transaction type means

Compensation award ×12
Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.
Form 4 Compensation award Tax / Compensation Filing 2026-10-02

HUM insider Form 4 filed for equity award, exercise, or tax withholding

HILZINGER KURT J (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award derivative · Restricted Stock Units 238 $384.91 $91.6K
Filing: Form 4 (Insider Transaction) Insider: HILZINGER KURT J (Director)
Form 4 Compensation award Tax / Compensation Filing 2026-09-03

HUM insider Form 4 filed for equity award, exercise, or tax withholding

Nundy Shantanu (Chief Medical Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award 2,549 — —
Filing: Form 4 (Insider Transaction) Insider: Nundy Shantanu (Chief Medical Officer) Shares: 2,549
Form 4 Compensation award Tax / Compensation Filing 2026-08-04

HUM insider Form 4 filed for equity award, exercise, or tax withholding

Smith Paul John (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award 544 — —
Filing: Form 4 (Insider Transaction) Insider: Smith Paul John (Director) Shares: 544
Form 4 Compensation award Tax / Compensation Filing 2026-08-04

HUM insider Form 4 filed for equity award, exercise, or tax withholding

Crawford Frederick John (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award 544 — —
Filing: Form 4 (Insider Transaction) Insider: Crawford Frederick John (Director) Shares: 544
Form 4 Compensation award Tax / Compensation Filing 2026-07-02

HUM insider Form 4 filed for equity award, exercise, or tax withholding

HILZINGER KURT J (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award derivative · Restricted Stock Units 233 $392.32 $91.4K
Filing: Form 4 (Insider Transaction) Insider: HILZINGER KURT J (Director)
Form 4 Compensation award Tax / Compensation Filing 2026-05-05

HUM insider Form 4 filed for equity award, exercise, or tax withholding

Mellet Celeste (Chief Financial Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award 15,387 — —
Filing: Form 4 (Insider Transaction) Insider: Mellet Celeste (Chief Financial Officer) Shares: 15,387
Form 4 Compensation award Tax / Compensation Filing 2026-05-05

HUM insider Form 4 filed for equity award, exercise, or tax withholding

Mehta Japan (Chief Information Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award 9,448 — —
Filing: Form 4 (Insider Transaction) Insider: Mehta Japan (Chief Information Officer) Shares: 9,448
Form 4 Compensation award Tax / Compensation Filing 2026-05-05

HUM insider Form 4 filed for equity award, exercise, or tax withholding

Dintenfass David (President, Enterprise Growth) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award 11,273 — —
Filing: Form 4 (Insider Transaction) Insider: Dintenfass David (President, Enterprise Growth) Shares: 11,273
Form 4 Compensation award Tax / Compensation Filing 2026-05-05

HUM insider Form 4 filed for equity award, exercise, or tax withholding

Rechtin James A. (President & CEO) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award 35,633 — —
Filing: Form 4 (Insider Transaction) Insider: Rechtin James A. (President & CEO) Shares: 35,633
Form 4 Compensation award Tax / Compensation Filing 2026-05-05

HUM insider Form 4 filed for equity award, exercise, or tax withholding

O'Hara Michelle A. (Chief Human Resources Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award 10,485 — —
Filing: Form 4 (Insider Transaction) Insider: O'Hara Michelle A. (Chief Human Resources Officer) Shares: 10,485
Form 4 Compensation award Tax / Compensation Filing 2026-05-05

HUM insider Form 4 filed for equity award, exercise, or tax withholding

Field Robert Stuart (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award 852 — —
Filing: Form 4 (Insider Transaction) Insider: Field Robert Stuart (Director) Shares: 852
Form 4 Compensation award Tax / Compensation Filing 2026-05-05

HUM insider Form 4 filed for equity award, exercise, or tax withholding

Ventura Joseph C (Chief Legal Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award 10,318 — —
Filing: Form 4 (Insider Transaction) Insider: Ventura Joseph C (Chief Legal Officer) Shares: 10,318
Material Events 7 · Form 8-K

An 8-K reports a material event in the window between scheduled reports. There are 7 in this period for Humana Inc. Each 8-K names the item number it is filed under, and that number is the fastest way to tell a routine disclosure from a consequential one.

Item 2.02 is an earnings release, Item 5.02 is a change of directors or officers, and Item 1.01 or 2.01 covers a material agreement or a completed acquisition. Item 7.01 and Item 8.01 are the general-purpose disclosure items and carry no fixed meaning on their own.

Form 8-K Material Company Update 2026-10-13

HUM filed 8-K — material company event

HUMANA INC filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
Form 8-K Material Company Update 2026-10-09

HUM filed 8-K — material company event

HUMANA INC filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
Form 8-K Material Company Update 2026-09-01

HUM filed 8-K — material company event

HUMANA INC filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
Form 8-K Material Company Update 2026-07-29

HUM filed 8-K — material company event

HUMANA INC filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
Form 8-K Material Company Update 2026-07-29

HUM filed 8-K — material company event

HUMANA INC filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
Form 8-K Material Company Update 2026-06-01

HUM filed 8-K — material company event

HUMANA INC filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
Form 8-K Material Company Update 2026-05-19

HUM filed 8-K — material company event

HUMANA INC filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
Periodic Reports 1 · Forms 10-K and 10-Q

The periodic reports are where the audited and reviewed financial statements live. This period contains 1 quarterly report (10-Q) for Humana Inc.

The two are not equivalent in weight. A 10-K is audited by an external firm and includes the full risk factor disclosure, business description and management discussion; a 10-Q is unaudited, reviewed rather than examined, and much shorter. When a figure in a quarterly report is later revised, the annual report is usually where the correction appears.

An amended report — 10-K/A or 10-Q/A — restates or corrects something in the original filing, and is worth reading against the version it replaces.

Form 10-Q Quarterly Report 2026-07-29

HUM filed Quarterly Report (10-Q)

HUMANA INC filed its quarterly report with the SEC. This report includes unaudited financial statements and management discussion for the quarter.

Filing: 10-Q (Quarterly Report)

How we classify Humana Inc.'s filings

Straight from EDGAR

Each displayed record links to an original source document. StrongBuyAnalytics provides navigation and brief excerpts or summaries, not the filing itself. Parsing may omit context or contain errors, so read the original document in full.

Transaction codes, not guesswork

The nature shown on each insider filing comes from the transaction code the filer entered on the form itself — P for an open-market purchase, A for a compensation award, F for shares withheld to pay tax, M for an option exercise. Where one filing contains several codes, the transaction table lists them line by line.

Why the distinction matters

Insider activity is routinely summarised as buying or selling, which flattens together decisions that mean very different things. Shares withheld for tax on a vesting grant are an automatic administrative step; shares bought on the open market are someone committing their own money at the current price.

What this page does not tell you

A filing records what happened, not why. Form 4 does not always disclose whether a sale was executed under a pre-arranged Rule 10b5-1 plan, and no single filing is a basis for a decision on HUM. Read these alongside the fundamentals rather than in isolation.

Frequently Asked Questions — HUM SEC Filings

More Tools for HUM

Want deeper HUM analysis?

View valuation, growth metrics, the rule-based stock-page score, demand zones, peer comparison, and more — all on the HUM stock analysis page.

HUM Full Analysis
Publisher, sources & limitations — September 15, 2026. StrongBuyAnalytics provides navigation and brief excerpts or summaries for educational use. Original filings remain at SEC EDGAR or other displayed source links; StrongBuyAnalytics does not author them. Filing dates are source dates, not publication dates for this page. Coverage can be delayed, incomplete, amended, or unavailable because of SEC/source availability, parsing, caching, or outages. Verify every material statement in the original filing.
Data Sources · Methodology · AI Disclosure · Corrections Policy · Disclaimer